These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 2436797)

  • 1. New strategies in cancer chemotherapy.
    Bonadonna G
    Cell Biophys; 1986 Dec; 9(1-2):243-56. PubMed ID: 2436797
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
    Dicke KA; Spitzer G
    Transplantation; 1986 Jan; 41(1):4-20. PubMed ID: 3001980
    [No Abstract]   [Full Text] [Related]  

  • 3. The evolution of cancer chemotherapy.
    Chabner BA
    Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose chemotherapy with stem cell rescue for solid tumours.
    Protheroe AS; Johnson PW
    Br J Hosp Med; 1996 Apr 3-16; 55(7):437-41. PubMed ID: 8730570
    [No Abstract]   [Full Text] [Related]  

  • 5. Safer cancer chemotherapy using a kinetically based experimental approach.
    Price LA; Hill BT
    Mt Sinai J Med; 1985 Jun; 52(6):452-9. PubMed ID: 3875025
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapeutic strategies for neoplasia.
    Talmadge JE
    Dev Biol Stand; 1992; 77():17-28. PubMed ID: 1426659
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions between antitumour agents and radiation and the expression of resistance.
    Hill BT
    Cancer Treat Rev; 1991 Sep; 18(3):149-90. PubMed ID: 1821327
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status and new vistas in combination chemotherapy.
    Frei E
    Mt Sinai J Med; 1985 Jun; 52(6):460-4. PubMed ID: 3875026
    [No Abstract]   [Full Text] [Related]  

  • 9. Navelbine: a new step in cancer therapy?
    Armand JP; Marty M
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current trends in the medical treatment of solid tumors].
    González Barón M
    An R Acad Nac Med (Madr); 1992; 109(2):253-8. PubMed ID: 1463143
    [No Abstract]   [Full Text] [Related]  

  • 11. The contribution of Gianni Bonadonna to the history of chemotherapy.
    Ribatti D
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):309-12. PubMed ID: 17216532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy--clinical trials and laboratory models.
    Wittes RE
    Cancer Treat Rep; 1986 Jan; 70(1):87-103. PubMed ID: 3510738
    [No Abstract]   [Full Text] [Related]  

  • 13. Teniposide: a review of 12 years of experience.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B; Marsoni S
    Cancer Treat Rep; 1984 Dec; 68(12):1455-66. PubMed ID: 6391663
    [No Abstract]   [Full Text] [Related]  

  • 14. The preclinical scientific basis for adjuvant chemotherapy in breast cancer.
    Griswold DP; Laster WR; Trader MW; Dykes DJ
    Recent Results Cancer Res; 1984; 96():1-7. PubMed ID: 6528086
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy--theory and practice.
    Capizzi RL; Keiser LW; Sartorelli AC
    Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
    [No Abstract]   [Full Text] [Related]  

  • 16. [Angiogenesis as a target for antitumor actions].
    Ushmorov AG; Aleksandrov VA
    Vopr Onkol; 1989; 35(3):263-70. PubMed ID: 2468258
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of certain cell kinetic and biological parameters for preoperative chemotherapy.
    Hill BT
    Recent Results Cancer Res; 1986; 103():41-53. PubMed ID: 3526475
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental chemotherapy of heterotransplanted Hodgkin- and non-Hodgkin-lymphoma cell lines in nude mice.
    Kirchner HH; Engert A; Diehl V
    Behring Inst Mitt; 1984 May; (74):329-36. PubMed ID: 6477360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy.
    Carter SK; Soper WT
    Cancer Treat Rev; 1974 Mar; 1(1):1-13. PubMed ID: 4534592
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases].
    Neretto G; Agricola R; Giovanelli E; Poccardi G; Pellerito R; Furno F; Martinetto P; Pellegrino S; Daglio C; Tondolo M
    Recenti Prog Med; 1980 Oct; 69(4):431-57. PubMed ID: 7006015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.